Jouanguy E - Search Results

1

Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.

Bastard P, Gervais A, Le Voyer T, Philippot Q, Cobat A, Rosain J, Jouanguy E, Abel L, Zhang SY, Zhang Q, Puel A, Casanova JL. Bastard P, et al. Among authors: jouanguy e. Immunol Rev. 2024 Mar;322(1):98-112. doi: 10.1111/imr.13304. Epub 2024 Jan 9. Immunol Rev. 2024. PMID: 38193358 Review.

2

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, Casanova JL. Jouanguy E, et al. N Engl J Med. 1996 Dec 26;335(26):1956-61. doi: 10.1056/NEJM199612263352604. N Engl J Med. 1996. PMID: 8960475 Free article. No abstract available.

3

Infections in IFNGR-1-deficient children.

Jouanguy E, Altare F, Lamhamedi-Cherradi S, Casanova JL. Jouanguy E, et al. J Interferon Cytokine Res. 1997 Oct;17(10):583-7. doi: 10.1089/jir.1997.17.583. J Interferon Cytokine Res. 1997. PMID: 9355958 Review.

4

Mendelian susceptibility to mycobacterial infection in man.

Altare F, Jouanguy E, Lamhamedi S, Döffinger R, Fischer A, Casanova JL. Altare F, et al. Among authors: jouanguy e. Curr Opin Immunol. 1998 Aug;10(4):413-7. doi: 10.1016/s0952-7915(98)80114-3. Curr Opin Immunol. 1998. PMID: 9722917 Review.

5

Interferon-gamma receptor deficiency: relationship between genotype, environment, and phenotype (Review).

Lamhamedi S, Jouanguy E, Altare F, Roesler J, Casanova JL. Lamhamedi S, et al. Among authors: jouanguy e. Int J Mol Med. 1998 Feb;1(2):415-8. doi: 10.3892/ijmm.1.2.415. Int J Mol Med. 1998. PMID: 9852244 Review.

6

IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men.

Jouanguy E, Döffinger R, Dupuis S, Pallier A, Altare F, Casanova JL. Jouanguy E, et al. Curr Opin Immunol. 1999 Jun;11(3):346-51. doi: 10.1016/s0952-7915(99)80055-7. Curr Opin Immunol. 1999. PMID: 10375558 Review.

7

Inheritable defects in interleukin-12- and interferon-gamma-mediated immunity and the TH1/TH2 paradigm in man.

Döffinger R, Jouanguy E, Altare F, Wood P, Shirakawa T, Novelli F, Lammas D, Kumararatne D, Casanova JL. Döffinger R, et al. Among authors: jouanguy e. Allergy. 1999 May;54(5):409-12. doi: 10.1034/j.1398-9995.1999.00088.x. Allergy. 1999. PMID: 10380770 Review. No abstract available.

8

Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion.

Dupuis S, Döffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, Abel L, Casanova JL. Dupuis S, et al. Among authors: jouanguy e. Immunol Rev. 2000 Dec;178:129-37. doi: 10.1034/j.1600-065x.2000.17810.x. Immunol Rev. 2000. PMID: 11213797 Review.

9

A virus finds its natural killer.

Casanova JL, Jouanguy E, Abel L. Casanova JL, et al. Among authors: jouanguy e. Nat Genet. 2001 May;28(1):7-9. doi: 10.1038/ng0501-7. Nat Genet. 2001. PMID: 11326263 No abstract available.

10

A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells.

Bernard F, Picard C, Cormier-Daire V, Eidenschenk C, Pinto G, Bustamante JC, Jouanguy E, Teillac-Hamel D, Colomb V, Funck-Brentano I, Pascal V, Vivier E, Fischer A, Le Deist F, Casanova JL. Bernard F, et al. Among authors: jouanguy e. Pediatrics. 2004 Jan;113(1 Pt 1):136-41. doi: 10.1542/peds.113.1.136. Pediatrics. 2004. PMID: 14702466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page